tiprankstipranks
Anixa Biosciences announces Phase 2 study for breast cancer vaccine
PremiumThe FlyAnixa Biosciences announces Phase 2 study for breast cancer vaccine
3M ago
Arm upgraded, Molson Coors downgraded: Wall Street’s top analyst calls
Premium
The Fly
Arm upgraded, Molson Coors downgraded: Wall Street’s top analyst calls
5M ago
Anixa Biosciences initiated with a Buy at EF Hutton
Premium
The Fly
Anixa Biosciences initiated with a Buy at EF Hutton
5M ago
Anixa Biosciences price target lowered to $7 from $12 at H.C. Wainwright
PremiumThe FlyAnixa Biosciences price target lowered to $7 from $12 at H.C. Wainwright
6M ago
Anixa Biosciences begins treating fifth patient in ovarian cancer CAR-T trial
Premium
The Fly
Anixa Biosciences begins treating fifth patient in ovarian cancer CAR-T trial
7M ago
Anixa Biosciences Forms Cancer Vaccine Partnership with Cleveland Clinic
Premium
Company Announcements
Anixa Biosciences Forms Cancer Vaccine Partnership with Cleveland Clinic
8M ago
Anixa Biosciences granted ovarian cancer vaccine technology patent in Japan
PremiumThe FlyAnixa Biosciences granted ovarian cancer vaccine technology patent in Japan
11M ago
Meet Anixa Biosciences: Fly exclusive interview with CEO Amit Kumar
Premium
The Fly
Meet Anixa Biosciences: Fly exclusive interview with CEO Amit Kumar
12M ago
Commercialization through large partner among Anixa goals, CEO tells The Fly
Premium
The Fly
Commercialization through large partner among Anixa goals, CEO tells The Fly
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100